The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choisy-Rossi, C.-M.
Right arrow Articles by Serreze, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choisy-Rossi, C.-M.
Right arrow Articles by Serreze, D. V.
The Journal of Immunology, 2004, 173: 3791-3800.
Copyright © 2004 by The American Association of Immunologists

Enhanced Pathogenicity of Diabetogenic T Cells Escaping a Non-MHC Gene-Controlled Near Death Experience1

Caroline-Morgane Choisy-Rossi, Thomas M. Holl, Melissa A. Pierce, Harold D. Chapman and David V. Serreze2

The Jackson Laboratory, Bar Harbor, ME 04609

For unknown reasons, the common MHC class I variants encoded by the H2g7 haplotype (Kd, Db) aberrantly elicit autoreactive CD8 T cell responses essential to type 1 diabetes development when expressed in NOD mice, but not other strains. In this study, we show that interactive non-MHC genes allow a NOD-derived diabetogenic CD8 T cell clonotype (AI4) to be negatively selected at far greater efficiency in C57BL/6 mice congenically expressing H2g7 (B6.H2g7). However, the few AI4 T cells escaping negative selection in B6.H2g7 mice are exported from the thymus more efficiently, and are more functionally aggressive than those of NOD origin. This provides mechanistic insight to previous findings that resistant mouse strains carry some genes conferring greater diabetes susceptibility than the corresponding NOD allele. In the B6.H2g7 stock, non-MHC gene-controlled elevations in TCR expression are associated with both enhanced negative selection of diabetogenic CD8 T cells and increased aggressiveness of those escaping this process. An implication of this finding is that the same phenotype, in this case relatively high TCR expression levels, could have double-edged sword effects, contributing to type 1 diabetes resistance at one level of T cell development, but at another actually promoting pathogenesis.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Mukhopadhaya, T. Hanafusa, I. Jarchum, Y.-G. Chen, Y. Iwai, D. V. Serreze, R. M. Steinman, K. V. Tarbell, and T. P. DiLorenzo
Selective delivery of {beta} cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice
PNAS, April 29, 2008; 105(17): 6374 - 6379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, C. M. Choisy-Rossi, A. E. Grier, T. M. Holl, H. D. Chapman, J. R. Gahagan, M. A. Osborne, W. Zhang, B. L. King, A. Brown, et al.
Through Regulation of TCR Expression Levels, an Idd7 Region Gene(s) Interactively Contributes to the Impaired Thymic Deletion of Autoreactive Diabetogenic CD8+ T Cells in Nonobese Diabetic Mice
J. Immunol., March 1, 2008; 180(5): 3250 - 3259.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. V. Serreze, M. A. Osborne, Y.-G. Chen, H. D. Chapman, T. Pearson, M. A. Brehm, and D. L. Greiner
Partial versus Full Allogeneic Hemopoietic Chimerization Is a Preferential Means to Inhibit Type 1 Diabetes as the Latter Induces Generalized Immunosuppression
J. Immunol., November 15, 2006; 177(10): 6675 - 6684.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-G. Chen, J. Chen, M. A. Osborne, H. D. Chapman, G. S. Besra, S. A. Porcelli, E. H. Leiter, S. B. Wilson, and D. V. Serreze
CD38 Is Required for the Peripheral Survival of Immunotolerogenic CD4+ Invariant NK T Cells in Nonobese Diabetic Mice.
J. Immunol., September 1, 2006; 177(5): 2939 - 2947.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Takaki, M. P. Marron, C. E. Mathews, S. T. Guttmann, R. Bottino, M. Trucco, T. P. DiLorenzo, and D. V. Serreze
HLA-A*0201-Restricted T Cells from Humanized NOD Mice Recognize Autoantigens of Potential Clinical Relevance to Type 1 Diabetes.
J. Immunol., March 1, 2006; 176(5): 3257 - 3265.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ueno, S. Cho, L. Cheng, Z. Wang, B. Wang, and Y. Yang
Diabetes Resistance/Susceptibility in T Cells of Nonobese Diabetic Mice Conferred by MHC and MHC-Linked Genes
J. Immunol., October 15, 2005; 175(8): 5240 - 5247.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Chen, C. Benoist, and D. Mathis
How defects in central tolerance impinge on a deficiency in regulatory T cells
PNAS, October 11, 2005; 102(41): 14735 - 14740.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
W. Jiang, M. S. Anderson, R. Bronson, D. Mathis, and C. Benoist
Modifier loci condition autoimmunity provoked by Aire deficiency
J. Exp. Med., September 19, 2005; 202(6): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-H. Lee, P. C. Reifsnyder, J. K. Naggert, C. Wasserfall, M. A. Atkinson, J. Chen, and E. H. Leiter
Novel Leptin Receptor Mutation in NOD/LtJ Mice Suppresses Type 1 Diabetes Progression: I. Pathophysiological Analysis
Diabetes, September 1, 2005; 54(9): 2525 - 2532.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. M. Pop, C. P. Wong, D. A. Culton, S. H. Clarke, and R. Tisch
Single cell analysis shows decreasing FoxP3 and TGF{beta}1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes
J. Exp. Med., April 18, 2005; 201(8): 1333 - 1346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.